Found: 10
Select item for more details and to access through your institution.
Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 158, doi. 10.1002/(SICI)1098-2299(199702)40:2<158::AID-DDR6>3.0.CO;2-K
- By:
- Publication type:
- Article
WAY-131256 is an orally active, efficacious, and in vivo functionally selective M<sub>1</sub> agonist.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 185, doi. 10.1002/(SICI)1098-2299(199702)40:2<185::AID-DDR8>3.0.CO;2-H
- By:
- Publication type:
- Article
Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 101, doi. 10.1002/(SICI)1098-2299(199702)40:2<101::AID-DDR1>3.0.CO;2-P
- By:
- Publication type:
- Article
Pharmacological strategies to selectively label and localize muscarinic receptor subtypes.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 104, doi. 10.1002/(SICI)1098-2299(199702)40:2<104::AID-DDR2>3.0.CO;2-P
- By:
- Publication type:
- Article
WAL 2014 FU (talsaclidine): A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 144, doi. 10.1002/(SICI)1098-2299(199702)40:2<144::AID-DDR5>3.0.CO;2-L
- By:
- Publication type:
- Article
Development of M<sub>1</sub> subtype selective muscarinic agonists for Alzheimer's disease: Translation of in vitro selectivity into in vivo efficacy.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 133, doi. 10.1002/(SICI)1098-2299(199702)40:2<133::AID-DDR4>3.0.CO;2-M
- By:
- Publication type:
- Article
Allosteric binding sites on muscarinic receptors.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 193, doi. 10.1002/(SICI)1098-2299(199702)40:2<193::AID-DDR9>3.0.CO;2-G
- By:
- Publication type:
- Article
Muscarinic receptor-mediated activation of nitric oxide synthase.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 205, doi. 10.1002/(SICI)1098-2299(199702)40:2<205::AID-DDR10>3.0.CO;2-K
- By:
- Publication type:
- Article
Development of a pharmacological target profile for muscarinic agonists.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 117, doi. 10.1002/(SICI)1098-2299(199702)40:2<117::AID-DDR3>3.0.CO;2-O
- By:
- Publication type:
- Article
Tetrahydropyrimidine derivatives display functional selectivity for M<sub>1</sub> muscarinic receptors in brain.
- Published in:
- Drug Development Research, 1997, v. 40, n. 2, p. 171, doi. 10.1002/(SICI)1098-2299(199702)40:2<171::AID-DDR7>3.0.CO;2-I
- By:
- Publication type:
- Article